MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
Gold Star Distribution, which supplies several Halal markets in the Twin Cities, is voluntarily recalling a list of food and ...
The Food and Drug Administration has recalled hundreds of products after a facility they were distributed from was found to ...
While no illness has been reported so far, the U.S. Food and Drug Administration says 54 stores in the state were affected by ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback